Agonandra: A Botanical Reference
1. Identity and Botanical Classification
Agonandra is a genus of woody plants belonging to the family Opiliaceae, within the order Santalales. It was described as a genus in 1862. Agonandra is native to Mesoamerica and South America. The formal full authority for the type species is Agonandra brasiliensis Miers ex Benth. & Hook.f., as recorded in Genera Plantarum [Bentham & Hooker f.] 1(1): 349 (1862).
The family Opiliaceae in Santalales comprises approximately 38 species within 12 genera distributed worldwide. The family Opiliaceae is divided into four tribes — Agonandreae, Anthoboleae, Champereieae, and Opilieae — according to the latest classification, comprising 12 genera and 38 species. Within Opiliaceae, Agonandra from the neotropics holds a phylogenetically notable position in the family.
A key biological trait of the genus is its parasitic ecology. Agonandra Miers ex Benth. comprises root hemiparasitic species. The life forms of the Opiliaceae family include trees, shrubs, and lianas; some species occur in evergreen primary or secondary forest, while others are found in more seasonal climates.
1.1 Species Within the Genus
Recognized species within Agonandra include: A. excelsa (Brazil, Bolivia, Peru, Paraguay, Ecuador, N Argentina); A. fluminensis (Rio de Janeiro); A. goldbergiana (Guatemala); A. macrocarpa (Yucatán, Costa Rica, Honduras, Nicaragua); A. obtusifolia (C + S Mexico); A. ovatifolia (Chiapas); A. peruviana (E Ecuador, N Peru, NW Brazil); A. racemosa (C + S Mexico, Guatemala, El Salvador, Honduras); and A. silvatica (Fr Guiana, Suriname, Guyana, Venezuela, N Brazil, Bolivia, Peru, Ecuador).
The most studied species in terms of both traditional use and scientific inquiry is Agonandra brasiliensis. It is a timber tree native to the Amazon rainforest and Cerrado vegetation in Brazil, where it is known by the Portuguese common name pau-marfim (ivory wood). It is a species of tree in the family Opiliaceae, native to Mato Grosso do Sul, Goiás, Acre, the Pantanal, Tocantins, Caatinga, Roraima, Amazônia, and a range of other Brazilian states and biomes.
The native range of A. brasiliensis extends from Panama to Guyana and Paraguay. It is a shrub or tree that grows primarily in the wet tropical biome. It is recorded as being used as animal food, a poison, and a medicine, as well as for fuel and food.
The second most ethnobotanically referenced species is Agonandra racemosa (DC.) Standl., which has a distribution centered in Central America and Mexico. In Mexican ethnobotanical records, A. racemosa (Opiliaceae) appears in the Sierra de Huautla Biosphere Reserve under the local name "Chicharroncillo," with leaves used for traditional purposes. In the Sierra de Huautla region of Morelos, Mexico, it is also recorded under the common name pegahueso — a name applied to Agonandra racemosa (DC.) Standl. — as a medicinal plant.
A further species, Agonandra excelsa, is a semideciduous tree with an open, more or less rounded crown, growing 8–10 metres tall, exceptionally to 15 metres, with a cylindrical bole of 20–40 cm in diameter and a thick bark. The tree is sometimes harvested from the wild for local use of its wood.
1.2 Common Names and Synonyms
- Agonandra brasiliensis: pau-marfim (Portuguese, Brazil); ivory wood (English). Synonyms include Agonandra duckei Huber ex Ducke.
- Agonandra racemosa: pegahueso (Mexico); chicharroncillo (Mexico, Sierra de Huautla). Known in Belize as Bejuco Verde, it is used ethnobotanically as a sedative, laxative, and treatment for gastritis and pain.
1.3 Plant Parts Used and Common Preparations
Different plant parts have been employed across traditions:
- The leaves are used in baths as a treatment for rheumatism.
- A decoction of the bark is used as a treatment for colds, diarrhoea, and malaria.
Preparations documented include aqueous decoctions of bark, leaf baths (topical), and dried plant material used in traditional compounding. No standardized commercial extract or dietary supplement product with a defined Agonandra identity has been formally registered with a major pharmacopeia or regulatory body.
2. Taxonomy and Phylogenetics
The order Santalales comprises approximately 18 families, 160 genera, and more than 2,200 species. Within this order, Agonandra is placed in the tribe Agonandreae of Opiliaceae. Phylogenetic analysis confirms its neotropical position: within Opiliaceae, Lepionurus, a monotypic shrub from South-East Asia, is the most basally placed genus, followed by Agonandra from the neotropics.
Molecular studies of Santalales have helped clarify the relationships of Opiliaceae to related parasitic plant families. Because the family possesses plesiomorphic and generalized traits that occur throughout the order, this diverse assemblage of hemiparasitic plants has been difficult to characterize and differentiate from related families. The Santalales as a whole are notable for their parasitic biology: the Sandalwood order (Santalales) are the largest, most diverse clade of parasitic plants in terms of growth habit, but all retain at least some chlorophyll and photosynthetic ability.
Two subspecies of Agonandra brasiliensis are recognized: subsp. brasiliensis and subsp. racemigera Hiepko.
3. Traditional and Historical Use
3.1 Brazil — Amazonia and Cerrado
In Brazil, Agonandra brasiliensis has a documented history of use in folk medicine across communities inhabiting the Amazon rainforest and the Cerrado savanna. The primary source records for these uses are ethnobotanical compendiums of Brazilian medicinal plants, principally the reference work by Mors, Rizzini, and Pereira (Medicinal Plants of Brazil), which lists approximately 1,500 species and varieties of plants with their botanical name, common name in Brazil, regions in Brazil where the plant is found, a brief list of uses, and any medically active compounds.
Documented traditional uses in Brazil include:
- Rheumatism: The leaves are used in baths as a treatment for rheumatism. This topical application in the form of a leaf bath is consistent with practices described for multiple Brazilian medicinal plants.
- Colds, diarrhoea, and malaria: A decoction of the bark is used as a treatment for colds, diarrhoea, and malaria.
- Multipurpose resource: The plant is used as animal food, a poison, and a medicine, as well as for fuel and food, reflecting a diverse spectrum of utility across rural communities.
3.2 Mexico and Central America — Agonandra racemosa
In Mexico, A. racemosa is documented as a constituent of traditional agroforestry systems and home-garden pharmacopoeias, particularly in tropical dry forest communities. It is recorded under the name pegahueso in ethnobotanical surveys of the Sierra de Huautla Biosphere Reserve (REBIOSH).
In Belize, the species known as Bejuco Verde (Agonandra racemosa (DC.) Standl.) is used for its sedative, laxative, and analgesic properties, and for the treatment of gastritis, according to records from the Belize Ethnobotany Project (1988), compiled by Michael J. Balick and colleagues.
3.3 Nature of Preparations and Temporal Context
The ethnobotanical record does not pinpoint a singular, ancient documented tradition analogous to, for instance, Ayurveda or traditional Chinese medicine. Rather, use of Agonandra species appears embedded in the broader continuum of Neotropical folk herbalism — a diverse and regionally variable body of knowledge transmitted across indigenous, mestizo, and rural communities of Brazil, Mexico, and Central America. The time period of these practices is difficult to date precisely, but they are reflected in ethnobotanical surveys primarily conducted between the 1980s and 2010s that document ongoing oral traditions predating systematic academic recording.
4. Key Constituents and Phytochemistry
Agonandra belongs to the Opiliaceae family, a family within Santalales. Phytochemical investigation of the genus is limited in the peer-reviewed English-language literature compared to more extensively studied botanical genera. The available evidence — largely derived from studies on A. brasiliensis — identifies the following compound classes and substances.
4.1 General Secondary Metabolite Profile
Studies on related genera of Opiliaceae provide context. In Opilia (a closely related genus in the same family), phytochemical screening revealed secondary metabolites including sterols, triterpenes, flavonoids, and tannins. Leaves and stem bark exhibited the highest total phenolic content and flavonoid levels.
For the family Opiliaceae as a whole, many phytochemical and pharmacological investigations have been done on Opilia genus members, and species within the family were found to have anti-inflammatory, antimicrobial, antioxidant, wound-healing, and anticancer activities.
4.2 Timber and Non-Medicinal Chemical Context
Agonandra brasiliensis is principally known as a timber tree and is often used for flooring and furniture, especially chair production. Its phytochemical profile has attracted less systematic pharmacognostic study than commercially important medicinal plants, and the peer-reviewed literature identifying and characterizing specific isolated bioactive compounds from Agonandra — such as named alkaloids, terpenoids, or phenolics unique to the genus — is sparse at the time of this writing. No NIH/NCCIH monograph, WHO monograph, ESCOP monograph, or European Pharmacopoeia entry for any Agonandra species has been published.
4.3 Botanical Family Chemistry as Contextual Background
Given that Agonandra belongs to the Santalales, it shares a botanical order with genera whose chemistry has been better characterized. The Santalales are the largest, most diverse clade of parasitic plants in terms of growth habit, and the group includes almost 2,000 species of trees, shrubs, mistletoes, and at least one mainly endophytic mistletoe. Hemiparasitic plants in this order commonly accumulate phenolic compounds, terpenes, and various secondary metabolites as a consequence of their ecological interactions with host plant tissues, but specific confirmation of these pathways in Agonandra awaits published dedicated phytochemical studies.
5. Scientific Evidence by Area of Use
Overall Evidence Summary: As of the date of this reference, no published human clinical trials or formal randomized controlled trials (RCTs) evaluating Agonandra species for any health outcome have been identified in major databases (PubMed/MEDLINE, Cochrane, ClinicalTrials.gov). No systematic reviews or meta-analyses of Agonandra are available. The evidence base is limited exclusively to ethnobotanical documentation and, to a very limited extent, preliminary in vitro or in vivo animal studies whose findings have not been validated in human populations. Each area below is assessed accordingly.
5.1 Anti-Rheumatic and Anti-Inflammatory Use
Traditional claim: Leaves used in baths as a treatment for rheumatism.
Scientific evidence: No controlled laboratory, animal, or clinical study specifically investigating Agonandra extracts for anti-inflammatory activity has been identified in the peer-reviewed literature. The use of leaf baths is a topical application; the mechanism, if any, is uncharacterized. This use remains at the level of ethnobotanical documentation only. Evidence strength: absent (traditional use only).
5.2 Antimalarial and Antiparasitic Use
Traditional claim: A decoction of the bark is used as a treatment for malaria.
Scientific evidence: No peer-reviewed experimental or clinical study testing Agonandra extracts against malaria-causing Plasmodium species or other parasites has been identified in available databases. The antimalarial claim is based solely on ethnobotanical records and has not been subjected to in vitro or in vivo pharmacological testing that is accessible in the peer-reviewed English-language literature. Evidence strength: absent (traditional use only).
5.3 Gastrointestinal Use (Diarrhoea, Gastritis, Laxative)
Traditional claims: A decoction of the bark is used as a treatment for diarrhoea. Additionally, in Belize, A. racemosa is used as a laxative and for gastritis.
Scientific evidence: No published pharmacological or clinical studies testing Agonandra preparations for gastrointestinal conditions have been identified. The laxative and antidiarrheal uses are contradictory in their directionality (one would reduce gut motility, the other increase it), suggesting either species-specific differences, dose-dependent effects, or regional variation in indication — all of which remain unexplored scientifically. Evidence strength: absent (traditional use only).
5.4 Sedative and Analgesic Use
Traditional claims: Agonandra racemosa is recorded in Belize as a sedative and analgesic.
Scientific evidence: No published preclinical or clinical studies have tested Agonandra preparations for sedative or analgesic effects. The claimed uses are derived from the Belize Ethnobotany Project. No mechanism of action has been proposed or tested for these properties. Evidence strength: absent (traditional use only).
5.5 Respiratory Use (Colds)
Traditional claim: A decoction of the bark is used as a treatment for colds.
Scientific evidence: No published study examining antiviral, antimicrobial, or immune-modulating activity of Agonandra preparations against cold-causing pathogens has been identified. Evidence strength: absent (traditional use only).
6. Body Systems and Health Areas
Based on traditional use documentation, Agonandra species have been associated with the following body systems and health areas. It must be stressed that these associations are based on ethnobotanical records and carry no validated scientific confirmation:
- Musculoskeletal system: Rheumatism treatment via leaf baths (A. brasiliensis).
- Gastrointestinal system: Diarrhoea treatment via bark decoction (A. brasiliensis); gastritis and laxative use (A. racemosa, Belize).
- Infectious disease / immune system: Malaria and colds treated with bark decoction (A. brasiliensis, Brazil).
- Nervous system: Sedative use (A. racemosa, Belize).
- Pain: Analgesic use (A. racemosa, Belize).
7. Dosage Forms and Reported Dosages
No standardized dosage information for any Agonandra preparation has been published in a peer-reviewed pharmacological study, pharmacopeial monograph, or regulatory agency document. The only dosage-form information available is qualitative:
- Bark decoction (oral): Boiling of dried or fresh bark in water. No quantity, concentration, or frequency has been specified in the reviewed ethnobotanical literature.
- Leaf bath (topical): Leaves prepared as a bath solution, applied externally to affected joints. No concentration or protocol is documented.
The absence of quantitative dosage data in the literature means that no safe or effective dose can be cited for any indication. This gap is consistent with the overall pre-clinical status of the scientific evidence base for this genus.
8. Safety Considerations
Formal toxicological studies — including acute toxicity, subchronic toxicity, genotoxicity, or reproductive toxicity studies — for Agonandra species are not represented in the peer-reviewed literature accessible through major databases. The following observations are factually verifiable:
- Recorded as a poison: According to Kew's Plants of the World Online, A. brasiliensis is documented as being used as a poison in addition to its food and medicinal uses. This dual role is consistent with the general pharmacology of many Neotropical plants and underscores the potential for toxicity at uncontrolled doses.
- No safety data from human studies: Because no human trials have been conducted, there are no data on adverse effects, drug interactions, contraindications, or safety in vulnerable populations (e.g., pregnant women, children, the elderly, or those with hepatic or renal impairment) derived from controlled research.
- Hemiparasitic plant chemistry considerations: As a root hemiparasite, Agonandra may accumulate secondary metabolites from host plants in addition to its own biosynthetic products. This chemical variability depending on host species is a recognized source of compositional unpredictability in hemiparasitic plant preparations, but no study has specifically characterized this variability in Agonandra.
- No pharmacopeial monograph: No national or international pharmacopeia (USP, European Pharmacopoeia, WHO, or Brazilian Pharmacopoeia) has issued a quality monograph for any Agonandra species. The absence of standardized quality control means commercial preparations cannot be assured to be of consistent potency or purity.
9. Research Gaps and Future Directions
Agonandra represents a genus at a very early — effectively pre-initiation — stage of pharmacological investigation. Across the peer-reviewed literature, the following foundational scientific work has not yet been published or made accessible:
- Dedicated phytochemical isolation and structural characterization of compounds from A. brasiliensis or A. racemosa.
- In vitro bioactivity screens (antimicrobial, anti-inflammatory, cytotoxic, antiparasitic) using authenticated extracts.
- In vivo animal models testing any of the traditional indications.
- Formal toxicology studies.
- Any human clinical trials of any design.
The context of the genus within the Santalales order — a phylogenetically and chemically rich group of parasitic and hemiparasitic plants — provides botanical rationale for exploratory phytochemical investigation. Closely related taxa within Opiliaceae, such as Opilia amentacea, have attracted more pharmacological attention; many phytochemical and pharmacological investigations have been conducted on the Opilia genus, and species within the family were found to have anti-inflammatory, antimicrobial, antioxidant, wound-healing, and anticancer activities. Whether these properties extend to Agonandra is an open empirical question.
The broader context of Brazilian ethnobotany provides scientific impetus for further study. A survey of medicinal plants reported to be antitumor agents in ethnobotanical research in Brazil raised the question of whether plant species used for tumor treatment in traditional Brazilian medicine have been sufficiently examined scientifically. A total of 84 medicinal plant species were reported to be used for cancer and tumor prevention or treatment in that analysis. At least one pharmacological study was found for only 35.71% of the species, highlighting the very wide gap between documented traditional use and formal scientific validation in Brazilian botanical medicine — a gap that applies fully to Agonandra.
References
Go back